(Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.)
Within the pharmaceutical sector it can be very hard to find a company that has the potential to grow substantially over the next few years. Often, investors shy away from the pharmaceutical sector simply because of the risks involved: from FDA decisions, to the launch of a product, the sector is fraught with risk. However, for those investors who are willing to take a chance, there is also the potential for significant gains. One particular company with a large amount of potential is IntelGenx Technologies (OTCQX:IGXT...
Only subscribers can access this article, which is part of the PRO research library covering 3,573 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: